Invenra, Astellas Pharma to Partner
Invenra is partnering with Astellas Pharma, a global pharmaceutical company with a vision to turn innovative science into value for patients, the company announced today. According to a release, the…
Invenra is partnering with Astellas Pharma, a global pharmaceutical company with a vision to turn innovative science into value for patients, the company announced today. According to a release, the…
Exact Sciences is collaborating with the Mayo Clinic to provide comprehensive genomic profiling and hereditary cancer tests to patients, the company announced recently. According to a release, the Mayo Clinic…
Usona Institute will begin its Phase 3 Clinical Trial investigating psilocybin for Major Depressive Disorder (MDD), the company announced today. According to a release, the uAspire trial will start with…
SHINE Technologies has signed a Memorandum of Understanding (MOU) with Orano to cooperate in the development of the U.S. pilot plant with commercial-scale technology for recycling used nuclear fuel from…
Exact Sciences has launched a hereditary cancer test in the United States called Riskguard, the company announced this week. According to a release, the test provides an individualized patient report…
Type One Energy announced today it is relocating to Clinton, Tenn., to build Infinity One, the company’s stellarator fusion prototype machine. According to a release, the project will be called…
Cellectar Biosciences enrolled its first patient in its Phase 1b clinical trial evaluating iopofosine I 131 in pediatric patients with relapsed or refractory malignant high-grade gliomas (pHGG), the company announced…
Elephas has closed a $55 million Series C funding round led by Venture Investors Health Fund and State of Wisconsin Investment Board (SWIB), the company announced today. “We remain intensely…
Cellular Logistics and Allele Biotech, a company that explores the mechanisms of biological processes to develop technologies and products for biomedical researchers, have partnered, the company announced recently. The two…
Cellectar Biosciences has partnered with Meaningful Insights-BioTech Analytics (MiBA), a data subsidiary of American Oncology Network (AON), the organization announced today. According to a release, the partnership will look to…